Literature DB >> 8112619

Production of human matrix metalloproteinase 3 (stromelysin) in Escherichia coli.

S A Rosenfeld1, O H Ross, J I Corman, M A Pratta, D L Blessington, W S Feeser, B D Freimark.   

Abstract

Full-length human matrix metalloproteinase 3 (prostomelysin or proMMP-3) was produced in Escherichia coli as an intracellular insoluble aggregate that could be solubilized and refolded to yield an activatable proenzyme. The refolded protein was purified to > 95% homogeneity. The recombinant proMMP-3 (re-proMMP-3) could be activated by agents known to stimulate self-catalyzed cleavage of native fibroblast proMMP-3. The N-terminal amino-acid sequence of the re-proMMP-3 and its activation products indicated that they were the same as those obtained with the natural material.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8112619     DOI: 10.1016/0378-1119(94)90770-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  Structural and inhibition analysis reveals the mechanism of selectivity of a series of aggrecanase inhibitors.

Authors:  Micky D Tortorella; Alfredo G Tomasselli; Karl J Mathis; Mark E Schnute; Scott S Woodard; Grace Munie; Jennifer M Williams; Nicole Caspers; Arthur J Wittwer; Anne-Marie Malfait; Huey-Sheng Shieh
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

2.  Efficient production of Thermus protease aqualysin I in Escherichia coli: effects of cloned gene structure and two-stage culture.

Authors:  S Sakamoto; I Terada; Y C Lee; K Uehara; H Matsuzawa; M Iijima
Journal:  Appl Microbiol Biotechnol       Date:  1996-03       Impact factor: 4.813

3.  Structure analysis reveals the flexibility of the ADAMTS-5 active site.

Authors:  Huey-Sheng Shieh; Alfredo G Tomasselli; Karl J Mathis; Mark E Schnute; Scott S Woodard; Nicole Caspers; Jennifer M Williams; James R Kiefer; Grace Munie; Arthur Wittwer; Anne-Marie Malfait; Micky D Tortorella
Journal:  Protein Sci       Date:  2011-04       Impact factor: 6.725

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.